France· FR:69714150
IRBESARTAN/HYDROCHLOROTHIAZIDE EG 300 mg/25 mg, comprimé pelliculé
A medicinal product containing hydrochlorothiazide + irbésartan, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HYDROCHLOROTHIAZIDE + IRBÉSARTAN
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400941971006plaquette(s) PVC PVDC aluminium de 30 comprimé(s)EUR 3.64
- cip133400941971464plaquette(s) PVC PVDC aluminium de 90 comprimé(s)EUR 10.53
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrochlorothiazide + irbésartan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCOAPROVELSanofi Winthrop Industrie, Gentilly
- SpainCOAPROVEL 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULASanofi Winthrop Industrie
- United KingdomCo-Irbesartan 150mg/12.5mg tabletsWaymade Healthcare Plc
- ItalyCOABESARTS.F. GROUP S.R.L.
- FinlandCoAprovelSanofi Winthrop Industrie
- United StatesAvalideSanofi-Aventis U.S. LLC
- SwedenCoAprovel 150 mg/12,5 mg Filmdragerad tablettSanofi Winthrop Industrie
- SwitzerlandCo-Irbesartan Sandoz
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Irbepress-Hct
- Belgium · Irbesartan/Hct Eg, Irbesartan/Hydrochloorthiazide Sandoz
- Bulgaria · Ko-Ирбесан, Ирпрезид
- Cyprus · Converide, Corycardon
- Czechia · Converide
- Germany · Irbecor Comp., Irbepress-Hct
- Denmark · Irbesartan/Hydrochlorthiazid Medical Valley, Irbesartan/Hydrochlorthiazid Stada
- Spain · Converide, Irbesartán /Hidroclorotiazida Sandoz
- United Kingdom (Northern Ireland) · Irbesartan And Hydrochlorothiazide, Irbesartan And Hydrochlorothiazide Bristol
- Greece · Converide, Irbegen Plus
- Hungary · Co-Irabel, Irbesartan Hct Sandoz
- Iceland · Coaprovel, Ifirmacombi
- Italy · Coabesart, Irbediur
- Liechtenstein · Coaprovel, Irbesartan Hydrochlorothiazide Zentiva
- Luxembourg · Irbesartan/Hct Eg, Irbesartan/Hydrochlorothiazid Micro Labs
- Malta · Converide, Irbesartan/ Hydrochlorothiazide Aurobindo
- Netherlands · Converide, Irbesartan Comp Hexal
- Norway · Coaprovel, Ifirmacombi
- Portugal · Converide, Irbesartan + Hidroclorotiazida Alter
- Romania · Izgrev
- Sweden · Irbesartan/Hydrochlorothiazide Stada, Irbesartan/Hydroklortiazid Actavis
- Slovakia · Converide
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4d5e05a-4323-4e1a-9bab-aebd900b8862 GET /v1/drugs/c4d5e05a-4323-4e1a-9bab-aebd900b8862?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69714150",
"date_amm": "2011-12-23",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "HYDROCHLOROTHIAZIDE + IRBÉSARTAN",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about hydrochlorothiazide + irbésartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.